Detection of adenovirus hepatitis and acute liver failure in allogeneic hematopoietic stem cell transplant patients.
Yoshiyuki OndaJunya KandaSoichiro SakamotoMutsumi OkadaNaoyuki AnzaiHiroshi UmadomeMasaro TashimaHironori HagaChihiro WatanabeNozomu HanaokaTsuguto FujimotoAkifumi Takaori-KondoPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2020)
Human adenovirus (HAdV) is an important cause of the common cold and epidemic keratoconjunctivitis in immunocompetent individuals. In immunocompromised patients, HAdV can sometimes cause severe infection such as cystitis, gastroenteritis, pneumonia, encephalitis, hepatitis, or disseminated disease, resulting in significant morbidity and also mortality. In particular, severe cases have been reported in patients after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Indeed HAdV has been recognized as a pathogen that requires careful monitoring in allo-HSCT patients. While HAdV hepatitis leading to severe acute liver failure is rare, such liver failure progresses rapidly and is often fatal. Unfortunately, HAdV hepatitis has few characteristic symptoms and physical findings, which makes it difficult to promptly confirm and start treatment. We report here four cases of HAdV hepatitis after allo-HSCT and their autopsy findings.
Keyphrases
- liver failure
- end stage renal disease
- hepatitis b virus
- ejection fraction
- chronic kidney disease
- hematopoietic stem cell
- prognostic factors
- allogeneic hematopoietic stem cell transplantation
- peritoneal dialysis
- cardiovascular disease
- mental health
- type diabetes
- physical activity
- depressive symptoms
- bone marrow
- early onset
- stem cell transplantation
- low dose
- candida albicans
- patient reported